Coronavirus Update: Pfizer Pledges To Double US Vaccine Output
Plus: Novavax Signs Pact For Equitable Vaccine Access
Executive Summary
A round-up of the latest developments, including Celltrion’s new antibody cocktail and SK Biosience and Novavax expanding their collaboration.
You may also be interested in...
How Pfizer Crafted Its Own ‘Operation Warp Speed’ For The COVID-19 Vaccine
It’s counter-intuitive, but not signing a commercial contract with BioNTech and refusing US federal funding were two of several moves Pfizer made to speed up development of its COVID-19 vaccine, CEO Albert Bourla says. Now it’s looking to supply low- and middle-income countries.
Adolescent Results Put Pfizer/BioNTech Ahead Of COVID Vaccine Pack, For Now
An EUA would carve out a market advantage, although Moderna should be releasing similar data soon for its COVID-19 vaccine.
Coronavirus Update: What’s The Window For J&J's COVID-19 Vaccine?
A round up of COVID-19 developments, including the CDC advising that it is "prudent" to start testing variant vaccines in case the South African B.1.351 strain gains a foothold in the US.